Literature DB >> 4665093

Glucagon-initiated human growth hormone release: a comparative study.

J P Cain, G H Williams, R G Dluhy.   

Abstract

Human growth hormone (HGH) responses in 20 healthy adults to subcutaneous glucagon, arginine infusion and tolbutamide and insulin hypoglycemia were compared. HGH rose in all four tests. HGH response to glucagon was also studied in 49 patients with suspected pituitary insufficiency, of whom 25 also later received an arginine infusion; an abnormal response to glucagon was the most frequent functional abnormality and often HGH was the only anterior pituitary hormone of which a deficiency was detectable. In seven subjects (two healthy controls and five patients with suspected hypopituitarism) there was a subnormal HGH response to arginine but a normal response to glucagon. It is concluded that glucagon is a simple and effective stimulus to HGH release, equal or superior to arginine, tolbutamide and insulin, and is an important test of anterior pituitary function.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4665093      PMCID: PMC1940964     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  16 in total

1.  Secretion of human growth hormone: physiologic and experimental modification.

Authors:  J ROTH; S M GLICK; R S YALOW; S A BERSON
Journal:  Metabolism       Date:  1963-07       Impact factor: 8.694

2.  Microdetermination of long-chain fatty acids in plasma and tissues.

Authors:  V P DOLE; H MEINERTZ
Journal:  J Biol Chem       Date:  1960-09       Impact factor: 5.157

3.  Hypopituitarism: a study of growth hormone and other endocrine functions.

Authors:  M T Rabkin; A G Frantz
Journal:  Ann Intern Med       Date:  1966-06       Impact factor: 25.391

4.  Late post-glucose rise in plasma growth hormone as a test of pituitary function.

Authors:  J M Streeto
Journal:  J Clin Endocrinol Metab       Date:  1970-07       Impact factor: 5.958

5.  Continuous blood glucose analysis in ambulatory fed subjects. II. Effects of anticoagulation with heparin.

Authors:  F J Service; G D Molnar; J W Rosevear; E Ackerman; W F Taylor; G M Cremer; K E Moxness
Journal:  Mayo Clin Proc       Date:  1969-07       Impact factor: 7.616

6.  Plasma glucose, non-esterified fatty acid, insulin and growth hormone response to glucagon in the newborn.

Authors:  R D Milner; A D Wright
Journal:  Clin Sci       Date:  1967-04       Impact factor: 6.124

7.  Sex-determined variation in serum insulin and growth hormone response to amino acid stimulation.

Authors:  T J Merimee; J A Bergess; D Rabinowitz
Journal:  J Clin Endocrinol Metab       Date:  1966-07       Impact factor: 5.958

8.  Plasma corticosteroids determined by use of corticosteroid-binding globulin and dextran-coated charcoal.

Authors:  C A Nugent; D M Mayes
Journal:  J Clin Endocrinol Metab       Date:  1966-10       Impact factor: 5.958

9.  Arginine-initiated release of human growth hormone. Factors modifying the response in normal man.

Authors:  T J Merimee; D Rabinowtitz; S E Fineberg
Journal:  N Engl J Med       Date:  1969-06-26       Impact factor: 91.245

10.  Hypoglycemia: a potent stimulus to secretion of growth hormone.

Authors:  J ROTH; S M GLICK; R S YALOW
Journal:  Science       Date:  1963-05-31       Impact factor: 47.728

View more
  10 in total

1.  Clinical characteristics, timing of peak responses and safety aspects of two dosing regimens of the glucagon stimulation test in evaluating growth hormone and cortisol secretion in adults.

Authors:  Kevin C J Yuen; Beverly M K Biller; Laurence Katznelson; Sharon A Rhoads; Michelle H Gurel; Olivia Chu; Valentina Corazzini; Kellie Spiller; Murray B Gordon; Roberto Salvatori; David M Cook
Journal:  Pituitary       Date:  2013-06       Impact factor: 4.107

2.  Glucagon and growth hormone.

Authors: 
Journal:  Br Med J       Date:  1973-01-27

Review 3.  Growth hormone-releasing hormone combined with arginine or growth hormone secretagogues for the diagnosis of growth hormone deficiency in adults.

Authors:  E Ghigo; G Aimaretti; E Arvat; F Camanni
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

4.  Comparative HGH response to i.v. glucagon and i.v. arginine stimulation tests in children and adolescents.

Authors:  Z Josefsberg; A Pertzelan; S Klonitzki-Peleg; R Kauli; A Silbergeld-Kowadlo; Z Laron
Journal:  Eur J Pediatr       Date:  1976-01-02       Impact factor: 3.183

5.  Glucagon stimulation test for the diagnosis of GH deficiency in adults.

Authors:  F L Conceição; A da Costa e Silva; A J Leal Costa; M Vaisman
Journal:  J Endocrinol Invest       Date:  2003-11       Impact factor: 4.256

6.  Overweight/Obese adults with pituitary disorders require lower peak growth hormone cutoff values on glucagon stimulation testing to avoid overdiagnosis of growth hormone deficiency.

Authors:  Laura E Dichtel; Kevin C J Yuen; Miriam A Bredella; Anu V Gerweck; Brian M Russell; Ariana D Riccio; Michelle H Gurel; Patrick M Sluss; Beverly M K Biller; Karen K Miller
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

7.  Evolving hypopituitarism as a consequence of traumatic brain injury (TBI) in childhood - call for attention.

Authors:  Milica Medic-Stojanoska; Sandra Pekic; Nikola Curic; Dragana Djilas-Ivanovic; Vera Popovic
Journal:  Endocrine       Date:  2007-06       Impact factor: 3.633

8.  Diagnosing growth hormone deficiency in adults.

Authors:  Nigel Glynn; Amar Agha
Journal:  Int J Endocrinol       Date:  2012-07-26       Impact factor: 3.257

9.  Glucagon stimulation testing in assessing for adult growth hormone deficiency: current status and future perspectives.

Authors:  Kevin C J Yuen
Journal:  ISRN Endocrinol       Date:  2011-08-11

10.  Signal Transduction Mechanisms for Glucagon-Induced Somatolactin Secretion and Gene Expression in Nile Tilapia (Oreochromis niloticus) Pituitary Cells.

Authors:  Chaoyi Zhang; Anji Lian; Yue Xu; Quan Jiang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-04       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.